CD38 is a potential treatment target in lymphoma patients concurrently infected with human immunodeficiency virus

Leuk Lymphoma. 2022 Jun;63(6):1479-1483. doi: 10.1080/10428194.2021.2023741. Epub 2022 Jan 12.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • ADP-ribosyl Cyclase 1
  • HIV
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Lymphoma* / complications
  • Lymphoma* / diagnosis
  • Lymphoma* / drug therapy

Substances

  • ADP-ribosyl Cyclase 1